Uncovering hidden depression: the critical role of depression screening in sleep disorders at U.S. sleep centers
Frontiers in Psychiatry · 25.04.2025 · 16
DOI: 10.3389/fpsyt.2025.1449360 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Psychiatry, online erschienen am 25.04.2025. Verfasst von Silvia Daccò und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Humanitas University, Milan, Italy. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Depression
Abstract (Originalsprache)
Introduction
Depression and sleep disorders are strongly linked, with sleep centers (SCs) reporting depressive symptoms in up to 63% of patients and depression diagnoses in 22%. Despite this, routine depression screening is not standard in SCs. This study aimed to identify patients meeting criteria for a current major depressive episode (cMDE) among those self-reporting clinically significant depressive symptoms (CSDS) in U.S. SCs.
Method
This retrospective sub-analysis of an ongoing multicenter trial included 147 adults (22–75 years) referred for sleep disorder evaluation. Participants underwent psychiatric assessments using the Mini-International Neuropsychiatric Interview and Patient Health Questionnaire-9 (PHQ-9), with CSDS defined as PHQ-9 ≥10. Descriptive statistics were compared between patients with/without a confirmed cMDE using non-parametric tests. Additional Mann-Whitney U tests assessed sleep characteristics by cMDE, major depressive disorder (MDD), and bipolar disorder (BD) (statistical significance, p < 0.05).
Results
Of 147 patients, 57 (38.8%) had a PHQ-9 score ≥10. Among them, 23 (40.3%) were diagnosed with cMDE: 17 (29.8%) met cMDD criteria, and 6 (10.5%) had BD, type I. A significantly lower cMDE prevalence was observed in patients without CSDS. Sleep characteristics showed no significant differences except for a lower N3 percentage in cMDE. BD, type I was associated with higher obstructive sleep apnea comorbidity compared to cMDD.
Discussion
Our findings suggest major depression prevalence in SCs is five times higher than in the general population, highlighting the need for routine depression screening and psychiatric confirmation. This also aids in identifying comorbidities and fostering tailored interventions to improve outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedical Sciences, Humanitas University, Milan, Italy.
- Personalized Medicine Center for Anxiety and Panic Disorders, Humanitas San Pio X Hospital, Milan, Italy.
- Clinical Research and Development Department, Medibio Limited, Savage, MN, United States.
Zitieren
APA
Daccò, S., Grassi, M., Wolpe, Z., Bruner, M., Caldirola, D., Perna, G., & Defillo, A. (2025). Uncovering hidden depression: the critical role of depression screening in sleep disorders at U.S. sleep centers. Frontiers in Psychiatry, 16. https://doi.org/10.3389/fpsyt.2025.1449360
Vancouver
Daccò S, Grassi M, Wolpe Z, Bruner M, Caldirola D, Perna G, et al. Uncovering hidden depression: the critical role of depression screening in sleep disorders at U.S. sleep centers. Frontiers in Psychiatry. 2025;16. doi:10.3389/fpsyt.2025.1449360
BibTeX
@article{Dacc2025,
author = {Daccò, Silvia and Grassi, Massimiliano and Wolpe, Zach and Bruner, Melissa and Caldirola, Daniela and Perna, Giampaolo and Defillo, Archie},
title = {Uncovering hidden depression: the critical role of depression screening in sleep disorders at U.S. sleep centers},
journal = {Frontiers in Psychiatry},
year = {2025},
volume = {16},
doi = {10.3389/fpsyt.2025.1449360}
}
EUVIMED